194 related articles for article (PubMed ID: 15525586)
1. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH
J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
[TBL] [Abstract][Full Text] [Related]
2. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
[TBL] [Abstract][Full Text] [Related]
3. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
4. Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats.
Cha JJ; Kang YS; Hyun YY; Han SY; Jee YH; Han KH; Han JY; Cha DR
Life Sci; 2013 Jun; 92(23):1118-24. PubMed ID: 23643633
[TBL] [Abstract][Full Text] [Related]
5. [Expression of VEGF in kidney of diabetic rats].
Chen ZJ; Yang YB; Huang SM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428
[TBL] [Abstract][Full Text] [Related]
6. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.
Fujita A; Sasaki H; Doi A; Okamoto K; Matsuno S; Furuta H; Nishi M; Nakao T; Tsuno T; Taniguchi H; Nanjo K
Diabetes Res Clin Pract; 2008 Jan; 79(1):11-7. PubMed ID: 17897750
[TBL] [Abstract][Full Text] [Related]
7. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats.
Ogawa M; Hirawa N; Tsuchida T; Eguchi N; Kawabata Y; Numabe A; Negoro H; Hakamada-Taguchi R; Seiki K; Umemura S; Urade Y; Uehara Y
Nephrol Dial Transplant; 2006 Apr; 21(4):924-34. PubMed ID: 16384826
[TBL] [Abstract][Full Text] [Related]
10. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
Yamabe N; Yokozawa T
J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
[TBL] [Abstract][Full Text] [Related]
11. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
[TBL] [Abstract][Full Text] [Related]
12. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
[TBL] [Abstract][Full Text] [Related]
13. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.
Kim HW; Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
Nephrology (Carlton); 2009 Oct; 14(7):681-8. PubMed ID: 19796028
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Zheng Z; Chen H; Xu X; Li C; Gu Q
Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy].
Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.
Kim NH; Oh JH; Seo JA; Lee KW; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Kidney Int; 2005 Jan; 67(1):167-77. PubMed ID: 15610240
[TBL] [Abstract][Full Text] [Related]
17. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
Jesmin S; Sakuma I; Hattori Y; Fujii S; Kitabatake A
Diabetologia; 2002 Mar; 45(3):402-15. PubMed ID: 11914746
[TBL] [Abstract][Full Text] [Related]
18. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of thiazolidinediones on diabetic nephropathy in OLETF rats.
Lee MY; Lee EY; Lee BJ; Won CS; Koh JH; Shin JY; Shin YG; Cho BP; Chung CH
Yonsei Med J; 2007 Apr; 48(2):301-7. PubMed ID: 17461531
[TBL] [Abstract][Full Text] [Related]
20. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS
J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
